Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and Curettage
To compare the effectiveness of combined antibiotic ophthalmic solution (neomycin sulfate,
polymyxin B sulfate and gramicidin) with placebo (artificial tear) in the treatment of
hordeolum after incision and curettage
Efficacy of the Combination Bismuth + Neomycin + Procaine in the Treatment of Recurrent Aphthous Ulceration
To evaluate the efficacy of the product Bismu-Jet ® (bismuth tartrate and sodium, neomycin
sulfate and procaine hydrochloride) produced by EMS S / A compared to placebo in reducing the
signs and symptoms resulting from UAR in patients of both sexes, with age over 12 years.
Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis
The primary objective of this study is to evaluate, through clinical parameters, the
effectiveness of your medicine topic Maxinom ® (dexamethasone, neomycin and polymyxin B -
Union Chemicals), comparing it to the topical medication Maxitrol ® (dexamethasone, neomycin
and polymyxin B - Alcon ) by the percentage of improvement (sustained response rate) at the
end of treatment, among the products studied.
A 48 hour patch test performed in healthy volunteers to determine the presensitization
(pre-existing allergy) of Neo-Synalar (neomycin sulfate 0.5%(0.35% neomycin base),
fluocinolone acetonide 0.025%) Cream . Subjects also receive a positive control (Sodium
Lauryl Sulfate) and a negative control (Saline).
The primary objective of this study is to determine if any subjects exhibit an allergic
reaction which may be indicative of a pre-existing sensitization.
Suture Contamination Rate in Adjustable Suture Strabismus Surgery
Bascom Palmer Eye Institute
1. To establish the culture positivity rate in adjustable suture strabismus surgery
2. To identify bacterial species and antibiotic susceptibility patterns of microorganisms
cultured from suture material
3. To compare suture contamination rates with techniques to reduce the suture contamination
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.